Nadeem’s expertise stems from scientific and business models at the intersection of genomics, data sciences and technology platforms for therapeutic innovation. He is currently: - Founder and Head: Transformational Prevention Unit, Novo Nordisk - Co-Chair: UK Dementia Mission (UK Government appointment) - Professor: School of Medicine, Edinburgh University He serves on: UK MRC Neuroscience and Mental Health Board; UK MRC Prevention Task and Finish Group; and UK Life Sciences Council Health Data Industry Expert Group. He advises UK Biobank, Genomics England, Our Future Health, Generation Scotland, Health Data Research UK and the UK Dementia Research Institute on industry applications of human genetics and data sciences for drug discovery and development.